Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 314281 - 314300 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania | (L01XA03) oxaliplatin | Oxaliplatin Kabi 5 mg/ml koncentratas infuziniam tirpalui 20 ml N1 (Fresenius Kabi Polska Sp.z.o.o., Lenkija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | FreseniusKabiPolskaSp.z.o.o.,Lenkija |
| Lithuania | (L01XA03) oxaliplatin | Oxaliplatin Accord 5 mg/ml koncentratas infuziniam tirpalui 40 ml, N1 (Accord Healthcare B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V.,Nyderlandai |
| Lithuania | (L01XD04) aminolevulinic acid | Gliolan 30 mg/ml milteliai geriamajam tirpalui N1 (photonamic GmbH & Co. KG, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Glioma | photonamicGmbH&Co.KG,Vokietija |
| Lithuania | (L01XG01) bortezomib | Bortezomib Accord 2,5 mg/ml injekcinis tirpalas 1,4 ml N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01XG01) bortezomib | Bortezomib Accord 2,5 mg/ml injekcinis tirpalas 1,4 ml N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01XG01) bortezomib | Bortezomib Accord 3,5 mg milteliai injekciniam tirpalui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01XG01) bortezomib | Bortezomib Fresenius Kabi 3,5 mg milteliai injekciniam tirpalui N1 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania | (L01XG01) bortezomib | Bortezomib Fresenius Kabi 3,5 mg milteliai injekciniam tirpalui N1 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania | (L01XG01) bortezomib | VELCADE 3,5 mg milteliai injekciniam tirpalui N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01XG02) carfilzomib | Kyprolis 60 mg milteliai infuziniam tirpalui N1 (Amgen Europe B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenEuropeB.V.,Nyderlandai |
| Lithuania | (L01XG02) carfilzomib | Kyprolis 60 mg milteliai infuziniam tirpalui N1 (Amgen Europe B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenEuropeB.V.,Nyderlandai |
| Lithuania | (L01XJ01) vismodegib | Erivedge 150 mg kietosios kapsulės N28 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Basal Cell | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L01XJ01) vismodegib | Erivedge 150 mg kietosios kapsulės N28 (Roche Registration GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Basal Cell | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L01XK01) olaparib | Lynparza 100 mg plėvele dengtos tabletės N56 (Abacus Medicine A/S, Danija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AbacusMedicineA/S,Danija |
| Lithuania | (L01XK01) olaparib | Lynparza 100 mg plėvele dengtos tabletės N56 (AstraZeneca AB, Švedija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AstraZenecaAB,Švedija |
| Lithuania | (L01XK01) olaparib | Lynparza 100 mg plėvele dengtos tabletės N56 (AstraZeneca AB, Švedija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AstraZenecaAB,Švedija |
| Lithuania | (L01XK01) olaparib | Lynparza 150 mg plėvele dengtos tabletės N56 (AstraZeneca AB, Švedija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AstraZenecaAB,Švedija |
| Lithuania | (L01XK01) olaparib | Lynparza 150 mg plėvele dengtos tabletės N56 (AstraZeneca AB, Švedija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AstraZenecaAB,Švedija |
| Lithuania | (L01XM02) ivosidenib | Tibsovo 250 mg plėvele dengtos tabletės N60 (Les Laboratoires Servier, Prancūzija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Cholangiocarcinoma | LesLaboratoiresServier,Prancūzija |
| Lithuania | (L01XX05) hydroxycarbamide | Hydrea 500 mg kietosios kapsulės N100 (CHEPLAPHARM Arzneimittel GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | CHEPLAPHARMArzneimittelGmbH,Vokietija |
Pages
